Case series analysis of immunophenotypic evolution during recurrence of low-grade endometrial stromal sarcoma: implications for molecular stability and clinical management - Scorecard - MDSpire
Advertisement
Case series analysis of immunophenotypic evolution during recurrence of low-grade endometrial stromal sarcoma: implications for molecular stability and clinical management
Clinical Scorecard: Analysis of Immunophenotypic Changes in Recurrent Low-Grade Endometrial Stromal Sarcoma: Insights into Molecular Stability and Clinical Implications
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Young women aged 22 to 34 years with LG-ESS.
Care Setting
Key Highlights
additional_comment
Guideline-Based Recommendations
Diagnosis
Diagnosis confirmed through imaging (e.g., MRI, CT) and pathological evaluation.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Hormonal therapy may be an important treatment strategy, but resistance can develop; consider potential side effects.
Clinical Best Practices
Re-evaluate hormone receptor status at recurrence for individualized treatment.
Conduct comprehensive pathological evaluations for accurate diagnosis.
Involve a multidisciplinary team for optimal management.
